EVIDENCE BASED MEDICINE I
WEEK 5
October 9, 2018
ANNOUNCEMENTS:
- Optional Literature Review help session on October 11th from 12 pm - 1pm in room F-118.
- Optional Peer Writing Tutoring Session - October 12th from 12-1 pm in the Regula Training room. See the Learning Center AIMS site for more information.
- Quiz 2 Review Session with Dr. Baughman - October 15th from 12- 1 pm in the NEW Center Auditorium
- Statistics calculations tutoring sessions
- November TBD from 12-1 pm in room TBD
- November TBD from 12-1 pm in room TBD
- Exam Review session - during class in November 13th
UPCOMING ASSESSMENTS:
- Literature Review is due at 5 pm on October 16th
- Statistics/research design quiz on October 16th
- Quiz is on October 30, 2018.
- Exam is on November 20th
____________________________________________________________________________
HOUR 1:
TOPIC: Literature Evaluation
FACULTY: Heather McEwen, MLIS, MS
LEARNING OBJECTIVES:
AT THE END OF THE LECTURE, STUDENTS WILL BE ABLE TO:
- Explain criteria for evaluating journals including impact factors and peer-review
- Evaluate a research article for your literature review assignment
- Apply FRISBEE to determine the validity of a research article
- Summarize the drug clinical trial process and apply that knowledge when evaluating articles
BRING TO CLASS: Your laptop and clicker
ASSIGNED READING:
SUPPLEMENTAL READING:
Optional: Greenhalgh’s How to Read Paper, Chapters 4-6, 9
CLASS RESOURCES:
- Evidence Based Medicine I course guide
- Literature Review assignment guide
- Citing Resources guide
- The Economist's Clinical Trial Simulator
- Example of a drug going through the clinical trial process:
- See chapters 6-8. In: Lopes RD, Harrington RA. eds. Understanding Clinical Research. New York, NY: McGraw-Hill; 2013. (In AccessMedicine)
- Svensson S, Menkes DB, Lexchin J. Surrogate outcomes in clinical trials: a cautionary tale. JAMA Intern Med. 2013;173(8):611-2.
- Compound Interest's Understanding the Drug Discovery Process
- Heneghan C, Goldacre B, Mahtani KR. Why clinical trial outcomes fail to translate into benefits for patients. Trials. 2017;18(1):122.
- FDAAA TrialsTracker
- Phases of Clinical Trials - Includes information on phases 2A, 2B, 3A, and 3B.
- The Economist: Some Science Journals That Claim to Peer Review Papers Do Not Do So article
- Successful Scientific Writing: Step by Step - by Paul Z. Siegel, MD, MPH -- CDC, Atlanta, GA
HOUR 2:
TOPIC: Discussing the Evidence with Your Patients
FACULTY: Joseph Zarconi, M.D.
LEARNING OBJECTIVES:
AT THE END OF THE LECTURE, STUDENTS WILL BE ABLE TO:
- Discuss the importance of an informed patient.
- List possible communication methods that clinicians can use to discuss the evidence with patients.
- Explain the five communication tasks to address with patients.
- Discuss the patient scenarios discussed in class.
CLASS RESOURCES:
- Evidence Based Medicine I course guide
SUPPLEMENTAL RESOURCES:
CLASS RESOURCES:
- Evidence Based Medicine I course guide
____________________________________________________________________________
ASSIGNED READINGS FOR NEXT WEEK’S CLASS:
TEST YOUR KNOWLEDGE:
- Professor McEwen’s lecture: The literature review assignment will help you assess your understanding of the topic.
UPCOMING ASSESSMENT
- Quiz next week – Quiz covers Dr. Baughman’s lectures (9/25/18, 10/2/18)